News
A group of vaccine-skeptical doctors and mandate opponents is challenging the CDC’s childhood immunization schedule in ...
For savvy investors looking for long-term businesses that not only dominate their industries today but also have the ...
ORLANDO, FL, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Stellar Market Research examines the growth rate of the Endocrinology Drugs Market during the forecasted period 2025-2032 The ...
The deal allows Eli Lilly and Company (NYSE:LLY) to have exclusive rights to develop and commercialize drug candidates ...
Viking Therapeutics offers a speculative opportunity, driven by its promising obesity drug pipeline. Click here to read more ...
Worldwide, 3·9 million individuals have kidney failure requiring maintenance dialysis.1,2 Considerable resources—more than 7% ...
Who benefits? The reduced price applies to self-paying patients—those without insurance, or whose insurance doesn’t cover ...
1d
TipRanks on MSNEli Lilly (LLY) Signs $1.3 Billion Deal with Superluminal to Discover Future Drugs Using AI
Eli Lilly (LLY) has signed a $1.3 billion deal with privately held biotechnology firm Superluminal Medicines that will see ...
Google issues cybersecurity warning as hackers exploit AI to steal passwords. FDA warns against unapproved sunscreens. Lilly ...
To provide a brief background, the TRAILBLAZER-ALZ 2 LTE study was a Phase 3, double-blind extension of the original ...
Eli Lilly Vs. Novo Nordisk: Correction Overly Done - GLP-1 Market Leadership/ Robust Pipelines Ahead
Novo Nordisk's (NVO) corrections amid AI market rotation might be an opportunity, due to GLP-1 market leadership & balanced ...
On Thursday, Eli Lilly and Co. (NYSE:LLY) said it will sharply increase the list price of its weight-loss and type 2 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results